Literature DB >> 24170319

Evaluating the reliability of Persian version of ankylosing spondylitis quality of life (ASQoL) questionnaire and related clinical and demographic parameters in patients with ankylosing spondylitis.

Sasan Fallahi1, Ahmad Reza Jamshidi, Katayoon Bidad, Mostafa Qorbani, Mahdi Mahmoudi.   

Abstract

Ankylosing spondylitis quality of life (ASQoL) is an instrument for assessing quality of life (QoL). The aims of this study were to assess the reliability of Persian version of ASQoL questionnaire and evaluation of QoL status and related factors in ankylosing spondylitis (AS). One hundred and sixty-three Iranian patients with AS who fulfilled modified New York criteria were enrolled. Patients were evaluated using questionnaires including demographic and clinical variables, Bath AS Disease Activity Index (BASDAI), Bath AS Functional Index (BASFI), fatigue, Bath AS Metrology Index, pain and ASQoL. Reliability and validity of Persian version of ASQoL were evaluated by test-re-test agreement, internal consistency and correlation with specific scales. Relationship of parameters with ASQoL was analyzed by multiple regression. Age, disease duration and ASQoL score (mean ± SD) were 37.74 ± 9.88, 14.49 ± 8.47 and 8.02 ± 5.28 years, respectively. Test-re-test reproducibility for ASQoL was good as assessed by intra-class correlation coefficient (ICC: 0.97, P < 0.001). Internal consistency was high (Cronbach's alpha: 0.91). Convergent validity was confirmed by correlation of ASQoL score with specific scales (BASFI, r = 0.74, BASDAI, r = 0.6, fatigue, r = 0.56, depression, r = 0.24, intermalleolar distance, r = -0.44 and educational level, r = -0.37). Persian version of ASQoL is a valid and reliable scale to assess QoL in AS. Function, fatigue, mood, hip mobility and education are the factors which should be noted to achieve the best QoL.

Entities:  

Mesh:

Year:  2013        PMID: 24170319     DOI: 10.1007/s00296-013-2888-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  Development and validation of the French ASQoL questionnaire.

Authors:  Thao Pham; Désirée M van der Heijde; Jacques Pouchot; Francis Guillemin
Journal:  Clin Exp Rheumatol       Date:  2010-06-23       Impact factor: 4.473

2.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.

Authors:  Katayoon Bidad; Sasan Fallahi; Mahdi Mahmoudi; Ahmadreza Jamshidi; Elham Farhadi; Alipasha Meysamie; Mohammad Hossein Nicknam
Journal:  Rheumatol Int       Date:  2011-11-20       Impact factor: 2.631

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness.

Authors:  K L Haywood; A M Garratt; K Jordan; K Dziedzic; P T Dawes
Journal:  Rheumatology (Oxford)       Date:  2002-11       Impact factor: 7.580

6.  Role of contextual factors in health-related quality of life in ankylosing spondylitis.

Authors:  V S Gordeev; W P Maksymowych; S M A A Evers; A Ament; L Schachna; A Boonen
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.

Authors:  T Y Zhu; L-S Tam; V W-Y Lee; W W Hwang; T K Li; K K Lee; E K Li
Journal:  Rheumatology (Oxford)       Date:  2008-07-17       Impact factor: 7.580

9.  Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report.

Authors:  E Collantes; P Zarco; E Muñoz; X Juanola; J Mulero; J L Fernández-Sueiro; J C Torre-Alonso; J Gratacós; C González; E Batlle; P Fernández; L F Linares; E Brito; L Carmona
Journal:  Rheumatology (Oxford)       Date:  2007-05-27       Impact factor: 7.580

10.  Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population.

Authors:  L K Zhao; Z T Liao; C H Li; T W Li; J Wu; Q Lin; F Huang; D T Yu; J R Gu
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 3.580

View more
  6 in total

1.  Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients.

Authors:  J Karami; M Mahmoudi; A Amirzargar; M Gharshasbi; A Jamshidi; S Aslani; M H Nicknam
Journal:  Genes Immun       Date:  2017-08-10       Impact factor: 2.676

2.  Effects of home-based exercise intervention on health-related quality of life for patients with ankylosing spondylitis: a meta-analysis.

Authors:  Hui Liang; Hua Zhang; Haiyan Ji; Chunmei Wang
Journal:  Clin Rheumatol       Date:  2015-03-15       Impact factor: 2.980

Review 3.  The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis.

Authors:  Qian He; Jing Luo; Jiaqi Chen; Jianying Yang; Chuanhui Yao; Caiqin Xu; Qingwen Tao
Journal:  Health Qual Life Outcomes       Date:  2022-07-30       Impact factor: 3.077

4.  Diagnostic Delay in Ankylosing Spondylitis: Related Factors and Prognostic Outcomes.

Authors:  Sasan Fallahi; Ahmad Reza Jamshidi
Journal:  Arch Rheumatol       Date:  2015-08-16       Impact factor: 1.472

5.  Are clinical measures influenced by various ethnic origins in Iranian patients with ankylosing spondylitis?A pilot study.

Authors:  Sasan Fallahi; Ahmad Reza Jamshidi; Mahdi Mahmoudi; Mostafa Qorbani
Journal:  Caspian J Intern Med       Date:  2014

6.  Gastrointestinal risk factors and patient-reported outcomes of ankylosing spondylitis in Korea.

Authors:  Sang-Hoon Lee; Yong-Wook Park; Jung-Yoon Choe; Kichul Shin; Seong-Ryul Kwon; Jin-Hye Cha; Young-Joo Kim; Juneyoung Lee; Tae-Hwan Kim
Journal:  Int J Rheum Dis       Date:  2019-12-29       Impact factor: 2.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.